Article Details

Inhibikase Therapeutics (NYSE:IKT) Trading 4% Higher - The AM Reporter

Retrieved on: 2022-12-30 06:45:39

Tags for this article:

Click the tags to see associated articles and topics

Inhibikase Therapeutics (NYSE:IKT) Trading 4% Higher - The AM Reporter. View article details on hiswai:

Excerpt

Renaissance Technologies LLC now owns 221,900 shares of the company's stock worth $165,000 after acquiring an additional 33,431 shares in the last ...

Article found on: reporter.am

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up